The most common tumor predisposition syndrome is neurofibromatosis type 1 (NF1), which is the consequence of a germline mutation of NF1, a tumor-suppressor gene located on chromosome 17. This evidence concerns the gene NF1 and BAP1-related tumor predisposition syndrome.